Latest News about Cantor Fitzgerald
Recent news which mentions Cantor Fitzgerald
Cannabis Analyst Advises Not To Buy WeedMaps Shares Until March
January 25, 2022
Tickers
MAPS
From Benzinga
Why Curaleaf Remains Among Top Cannabis Picks - Analyst's Thoughts On Recent Acquisition Spree
January 04, 2022
From Benzinga
From Benzinga
Why Isn't TerrAscend Stock Among This Analyst's Top Picks?
December 08, 2021
From Benzinga
Cantor Lowers Price Target On Trulieve But The Stock Is Still Their Top Pick Among MSOs
December 06, 2021
From Benzinga
Rumble SPAC Partner CF Acquisition Shares Spike On Donald Trump Partnership: What Investors Should Know
December 03, 2021
From Benzinga
As Consolidation Hits Canadian Cannabis Retail This Undervalued Stock Appears On Analyst's Radar
November 23, 2021
From Benzinga
Analyst: Possibilities Endless For Sundial As Canadian Cannabis Retail Consolidates
November 15, 2021
From Benzinga
What Will Drive Columbia Care's Future Growth? Analyst Opines Post Positive Q3 Earnings
November 12, 2021
Tickers
CCHWF
From Benzinga
As Green Thumb's Shares Go Up Post Earnings, Analyst Says Stock Will Benefit From Cannabis Legalization
November 11, 2021
Tickers
GTBIF
From Benzinga
MedMen Still On Track To Be Premier Cannabis Retailer Despite Litigation Hurdles, Analyst's Take On Q1 Earnings
November 11, 2021
From Benzinga
Canopy Growth's BioSteel Taps Woman's Basketball Prodigy Azzi Fudd As New Ambassador
November 10, 2021
Tickers
CGC
From Benzinga
Why Curaleaf Should Be A Core Holding In Any US MSO Portfolio: Analyst's Take On Q3 Earnings
November 09, 2021
Tickers
CURLF
From Benzinga
Curaleaf 'On Track To Achieve $1.2 To $1.3B Annual Revenue Guidance,' Q3 Revenue Grows 74% YoY
November 09, 2021
Tickers
CURLF
From Benzinga
Will $286M Tryke Deal Improve Curaleaf's Operating Margin? Analyst's Thoughts Ahead Earnings
November 08, 2021
From Benzinga
As Canopy's Shares Dive Post-Earnings, Analyst Calls Stock 'Bellwether,' Sensitive To Fed Reform News
November 05, 2021
From Benzinga
Canopy Growth Reports $16.3M In Q2 Net Loss, Sales Of $131.4M, Pushes Out Positive Adjusted EBITDA Target
November 05, 2021
Tickers
CGC
From Benzinga
What's In The Cards For Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings Season
November 04, 2021
From Benzinga
What Can Help Canopy Growth Reach $250M In Sales? Analyst's Thoughts Ahead Of Earnings
November 03, 2021
From Benzinga
What Will Drive Aurora Cannabis' Value Most? Analyst's Thoughts Ahead Of Q1 Earnings Report
October 28, 2021
From Benzinga
Is The Worst Over For HEXO Stock? This Analyst Explains What To Expect From Q4 Earnings
October 28, 2021
Tickers
HEXO
From Benzinga
From Benzinga
Why MSO Uplistings Could Be The Next Major Cannabis Stock Catalyst
October 13, 2021
From Benzinga
What Investors Need To Know On Heels Of Tilray's Q1 Earnings Release
October 08, 2021
Tickers
TLRY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.